Original Research

Published on 04 Dec 2023

Price increase negotiations to address drug shortages in South Korea’s national health insurance

in Drugs Outcomes Research and Policies

Seung Rae Yu
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1307462

2,775 views
1 citation

Original Research

Published on 04 Dec 2023

Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse

in Drugs Outcomes Research and Policies

Jia-jia Huang
Ji-zhen Cai
Zhi-peng Zhou
Yan Liu
Zhen-jia Yang
Da-zheng Li
Yu-hua Chen
Ying-yi Luan
Yong-ming Yao
Ming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1281235

1,815 views
1 citation

Original Research

Published on 04 Dec 2023

Online information and availability of three doping substances (anabolic agents) in sports: role of pharmacies

in Drugs Outcomes Research and Policies

Juan F. Garcia
Jesús Seco-Calvo
Soledad Arribalzaga
Raquel Díez
Cristina Lopez
M. Nelida Fernandez
Juan J. Garcia
M. Jose Diez
Raul de la Puente
Matilde Sierra

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1305080

2,480 views
1 citation

Original Research

Published on 30 Nov 2023

Evaluating the effectiveness of the Ministry of Health restriction policy on seasonal antibiotic consumption trends in Saudi Arabia, 2016–2020

in Drugs Outcomes Research and Policies

Khaloud O. Alzahrani
Saeed M. Alshahrani
Sulaiman M. Alajel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242087

2,753 views

Original Research

Published on 28 Nov 2023

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

in Drugs Outcomes Research and Policies

Juan Carlos Rejon-Parrilla
Jaime Espin
Sarah Garner
Stanislav Kniazkov
David Epstein

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199500

6,789 views
2 citations

Perspective

Published on 28 Nov 2023

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

in Drugs Outcomes Research and Policies

Alessandra I. G. Buma
Berber Piet
Rob ter Heine
Michel M. van den Heuvel
Paul Brinkman
Daan van den Broek
Sjaak Burgers
Francesco Ciompi
Simona M. Cristescu
Bram van Ginneken

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274532

1,634 views

Opinion

Published on 24 Nov 2023

Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment

in Drugs Outcomes Research and Policies

Rachele M. Hendricks-Sturrup
Lauren M. Edgar
Christine Y. Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1276396

1,024 views

Methods

Published on 24 Nov 2023

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes

in Drugs Outcomes Research and Policies

Karolina Zebrowska
Rosa C. Banuelos
Evelyn J. Rizzo
Kathy W. Belk
Gary Schneider
Koen Degeling

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249998

1,593 views
1 citation

Review

Published on 23 Nov 2023

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges

in Drugs Outcomes Research and Policies

Xin Chen
Ruyue He
Xinyi Chen
Liyun Jiang
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261312

2,204 views
2 citations

Original Research

Published on 22 Nov 2023

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity

in Drugs Outcomes Research and Policies

Wenyun Yang
Ruyue He
Yuehan Sun
Fangrong Yan
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266322

1,213 views

Correction

Published on 22 Nov 2023

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

in Drugs Outcomes Research and Policies

Geok Ying Chun
Nurul Ain Mohd Tahir
Farida Islahudin
Veena Selvaratnam
Shu Chuen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1336072

493 views

Original Research

Published on 21 Nov 2023

Healthcare professional perspectives on medication challenges in the post-stroke patient

in Drugs Outcomes Research and Policies

Shauna Bell
Helen Kelly
Eva Hennessy
Margaret Bermingham
Jennifer Raymy O’Flynn
Laura J. Sahm

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266277

1,769 views
1 citation

Original Research

Published on 21 Nov 2023

Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis

in Drugs Outcomes Research and Policies

Han Xie
Xinyi Chen
Min Xue
Huaying Li
Yonghan Ge
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1268793

926 views

Editorial

Published on 21 Nov 2023

Editorial: Effective methods to promote appropriate use of medicines

in Drugs Outcomes Research and Policies

Yen-Ming Huang
Yuki Kondo
Tomoya Tachi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331906

1,270 views

Correction

Published on 17 Nov 2023

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Xikui Lu
Lu Zhang
Hangxing Huang
Xiangping Wu
Zhenting Wang
Ling Huang
Jingyang Li
Huimin Yu
Hongyan Zhang
Jian Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1327256

736 views

Systematic Review

Published on 17 Nov 2023

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Jiyifan Li
Chenyang Zhu
Jingru Liang
Jiarong Hu
Haiyang Liu
Zihan Wang
Ruifang Guan
Junwei Chow
Shiwei Yan
Longzhou Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303694

2,968 views
6 citations

Navigation group

Articles

Price increase negotiations to address drug shortages in South Korea’s national health insurance

Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse

Online information and availability of three doping substances (anabolic agents) in sports: role of pharmacies

Evaluating the effectiveness of the Ministry of Health restriction policy on seasonal antibiotic consumption trends in Saudi Arabia, 2016–2020

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

Healthcare professional perspectives on medication challenges in the post-stroke patient

Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis

Editorial: Effective methods to promote appropriate use of medicines

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis